Xiaoyu Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiaoyu Yang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Chunliang Li
Department of Tumor Cell Biology, St. Jude Children’s Research Hospital, Memphis, USA
46 shared publications - Chunyan Zong
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
46 shared publications - Fengqin Fang
Tongren Hospital, Shanghai, China
46 shared publications - Guopei Zheng
Department of Ophthalmology, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
46 shared publications - Jianfeng Shen
Department of Ophthalmology, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
46 shared publications - Jie He
Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
46 shared publications
Latest Publications
- Open Access
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from PIKfyve Inhibition Induces Antitumor Immunogenicity by Attenuating STING Trafficking and Lysosomal Degradation
Supplementary Table 4 from PIKfyve Inhibition Induces Antitumor Immunogenicity by Attenuating STING Trafficking and Lysosomal Degradation
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from PIKfyve Inhibition Induces Antitumor Immunogenicity by Attenuating STING Trafficking and Lysosomal Degradation
Supplementary Table 4 from PIKfyve Inhibition Induces Antitumor Immunogenicity by Attenuating STING Trafficking and Lysosomal Degradation
- Open Access
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from PIKfyve Inhibition Induces Antitumor Immunogenicity by Attenuating STING Trafficking and Lysosomal Degradation
ShRNA and sgRNA target sequences
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from PIKfyve Inhibition Induces Antitumor Immunogenicity by Attenuating STING Trafficking and Lysosomal Degradation
ShRNA and sgRNA target sequences
- Open Access
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from PIKfyve Inhibition Induces Antitumor Immunogenicity by Attenuating STING Trafficking and Lysosomal Degradation
Supplementary Table 3 from PIKfyve Inhibition Induces Antitumor Immunogenicity by Attenuating STING Trafficking and Lysosomal Degradation
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from PIKfyve Inhibition Induces Antitumor Immunogenicity by Attenuating STING Trafficking and Lysosomal Degradation
Supplementary Table 3 from PIKfyve Inhibition Induces Antitumor Immunogenicity by Attenuating STING Trafficking and Lysosomal Degradation
- Open Access
- 19 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from PIKfyve Inhibition Induces Antitumor Immunogenicity by Attenuating STING Trafficking and Lysosomal Degradation
ShRNA and sgRNA target sequences
- 19 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from PIKfyve Inhibition Induces Antitumor Immunogenicity by Attenuating STING Trafficking and Lysosomal Degradation
ShRNA and sgRNA target sequences